{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:37:18Z","timestamp":1767861438478,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK132781"],"award-info":[{"award-number":["DK132781"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001172","name":"Hormel Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajpath.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:26:40Z","timestamp":1717590400000},"page":"1528-1537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["NAMPT Overexpression Drives Cell Growth in Polycystic Liver Disease through Mitochondrial Metabolism Regulation"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-6616","authenticated-orcid":false,"given":"Kishor","family":"Pant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-3634","authenticated-orcid":false,"given":"Sergio A.","family":"Gradilone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.04.010_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pathol-042320-121247","article-title":"Polycystic liver disease: advances in understanding and treatment","volume":"17","author":"Masyuk","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","article-title":"Clinical management of polycystic liver disease","volume":"68","author":"van Aerts","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/HMER.S377530","article-title":"Polycystic liver disease: pathophysiology, diagnosis and treatment","volume":"14","author":"Norcia","year":"2022","journal-title":"Hepatic Med"},{"key":"10.1016\/j.ajpath.2024.04.010_bib4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2011.04.030","article-title":"Polycystic liver diseases: congenital disorders of cholangiocyte signaling","volume":"140","author":"Strazzabosco","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.04.010_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","article-title":"Nampt: linking NAD biology, metabolism and cancer","volume":"20","author":"Garten","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2024.04.010_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115607","article-title":"Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery","volume":"258","author":"Tang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ajpath.2024.04.010_bib7","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/hep.32080","article-title":"Histone deacetylase sirtuin 1 promotes loss of primary cilia in cholangiocarcinoma","volume":"74","author":"Pant","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.04.010_bib8","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1158\/0008-5472.CAN-14-0809","article-title":"Synergy between the NAMPT inhibitor GMX1777(8) and pemetrexed in non-small cell lung cancer cells is mediated by PARP activation and enhanced NAD consumption","volume":"74","author":"Chan","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.04.010_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BC20040089","article-title":"Cytoskeletal and motor proteins facilitate trafficking of AQP1-containing vesicles in cholangiocytes","volume":"98","author":"Tietz","year":"2006","journal-title":"Biol Cell"},{"key":"10.1016\/j.ajpath.2024.04.010_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cells12050775","article-title":"The NAMPT inhibitor FK866 in combination with cisplatin reduces cholangiocarcinoma cells growth","volume":"12","author":"Pant","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.04.010_bib10","article-title":"Short-chain fatty acid butyrate induces cilia formation and potentiates the effects of HDAC6 inhibitors in cholangiocarcinoma cells","volume":"9","author":"Pant","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ajpath.2013.11.027","article-title":"HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis","volume":"184","author":"Gradilone","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/hep.32298","article-title":"Autophagy promotes hepatic cystogenesis in polycystic liver disease via depletion of cholangiocyte ciliogenic proteins","volume":"75","author":"Masyuk","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.04.010_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2018.05.024","article-title":"Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.04.010_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cgh.2016.03.008","article-title":"Polycystic liver disease: the benefits of targeting cAMP","volume":"14","author":"Masyuk","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib16","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1038\/s41467-022-35537-2","article-title":"Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.04.010_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.ajpath.2024.04.010_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.564","article-title":"NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by [beta]-lapachone","volume":"6","author":"Moore","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2024.04.010_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.970553","article-title":"Review of various NAMPT inhibitors for the treatment of cancer","volume":"13","author":"Wei","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/nu13051665","article-title":"Advances in NAD-lowering agents for cancer treatment","volume":"13","author":"Ghanem","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpath.2024.04.010_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2024.04.010_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/neuonc\/noab175","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress","volume":"24","author":"Sharma","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100903","article-title":"Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells","volume":"41","author":"Carreira","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpath.2024.04.010_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2024.04.010_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.883318","article-title":"NAMPT inhibition induces neuroblastoma cell death and blocks tumor growth","volume":"12","author":"Vallejo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2024.04.010_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-020-00264-0","article-title":"Inhibition of nicotinamide\u00a0phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma","volume":"9","author":"Gibson","year":"2020","journal-title":"Oncogenesis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:09:37Z","timestamp":1762081777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0002944024001974"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.04.010","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAMPT Overexpression Drives Cell Growth in Polycystic Liver Disease through Mitochondrial Metabolism Regulation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}